Bain Capital Life Sciences Partners, LP
CIK 1703030 · last filed 2026-05-22
Bain Capital Life Sciences Partners, LP is a corporate insider who has filed 4 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for RPID, was dated May 22, 2026. Across all open-market trades the lifetime net is −$159.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $14.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$14.84M
3
4
-$159.35M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RPID | 10%+ Owner | 8,434,560 | $1.76 | $14.84M | $0 | 1 | 2026-05-22 |
| Aptinyx Inc. (APTX) Delisted | 10%+ Owner | 8,891,758 | $0.06 | $542.4K | $60.00M | 1 | 2020-10-27 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | Director | 5,580,237 | $38.22 | $213.28M | -$219.34M | 2 | 2019-11-21 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | RPID | Buy (P) | — | $0 | EDGAR |
| 2020-10-27 | Aptinyx Inc. (APTX) Delisted | Buy (P) | +19,999,998 | $60.00M | EDGAR |
| 2019-11-21 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Sell (S) | −10,500,000 | -$231.31M | EDGAR |
| 2017-12-19 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Mixed | +53,581,422 | $11.97M | EDGAR |